Unrealistic optimism and the ethics of phase I cancer research.
Unrealistic optimism and the ethics of phase I cancer research.
复制标题
DOI:
10.1136/medethics-2012-100752
复制
发表时间:
2013-06
影响因子:
4.1
通讯作者:
Kodish E
中科院分区:
文献类型:
--
作者:
Crites J;Kodish E
One of the most pressing ethical challenges facing Phase I cancer research centers on the process of informed consent. Historically, most scholarship has been devoted to redressing therapeutic misconception—i.e., the conflation of the nature and goals of research with those of therapy. While therapeutic misconception continues to be a major ethical concern, recent scholarship has begun to recognize that the informed consent process is more complex than merely a transfer of information and therefore cannot be evaluated only according to how well an individual understands such information. Other components of decision making operate independently of understanding and yet still may compromise the quality of informed consent. Notable among these components is unrealistic optimism, an event-specific belief that one has a better chance of receiving benefit than others similarly situated. In this article, we consider responses to interviews with parents who had recently completed an informed consent conference for enrolling their child in a Phase I cancer clinical trial to examine how this influence manifests and how investigators might address it during informed consent.
登录
查看更多内容
影响因子:
6.2
作者:
Sulmasy, Daniel P.;Astrow, Alan B.;He, M. Kai;Seils, Damon M.;Meropol, Neal J.;Micco, Ellyn;Weinfurt, Kevin P.
通讯作者:
Weinfurt, Kevin P.
影响因子:
7.6
作者:
WEINSTEIN, ND
通讯作者:
WEINSTEIN, ND
影响因子:
2.7
作者:
Bergenmar, Mia;Johansson, Hemming;Wilking, Nils
通讯作者:
Wilking, Nils
影响因子:
4.1
作者:
Jansen, Lynn A.
通讯作者:
Jansen, Lynn A.
影响因子:
1.2
作者:
Weinfurt, KP
通讯作者:
Weinfurt, KP